The global polyclonal antibody market is poised for significant expansion in the coming decade, driven by increasing ...

ADMA continues to maintain momentum in 2025 after its stupendous performance in 2024. Strong demand for Asceniv should fuel growth.

This useful study presents findings on the developmental roles of Nup107, a key nucleoporin, in regulating the larval-to-pupal transition in Drosophila melanogaster through its involvement in ecdysone ...

Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and ...

Mammalian genomes are organized by multi-level folding, yet how this organization contributes to cell type-specific transcription remain unclear. We uncovered that the nuclear protein SATB1 ...

James Harrison’s legacy is at the heart of a wild story about canny science, boundless goodwill and an errant blood transfusion vanquishing a devastating and deadly disease.

More information: Oluwafemi F. Adu et al, Structures and functions of the limited natural polyclonal antibody response to parvovirus infection, Proceedings of the National Academy of Sciences (2025).

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

Swarm Oncology Ltd. ('Swarm Oncology' or 'Swarm'), a biotechnology company pioneering novel T cell therapies to achieve long-term remission in patients with advanced solid cancers, today announced a ...